Showing results (1711-1720 of 2,038) with videos related to

Sort By:
Pageof 204
Nature Communications|September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancerKevin Chang, Henry M Delavan, Elizabeth Yip, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Nature Communications|September 27, 2016
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionYashar S Niknafs, Sumin Han, Teng Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Cancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Nature Communications|March 20, 2021
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancerMusaddeque Ahmed, Fraser Soares, Ji-Han Xia, et al.
Pageof 204